my account  log out
 

Tamoxifen

Create: 12/18/2017
Expired Date:12/01/2019
Category: Aldehyde intermediates [Chemical]
Message:Tamoxifen Product Name: Tamoxifen Synonyms: (z)-2-(4-(1,2-diphenyl-1-butenyl)phenoxy)phenoxy)-n,n-dimethylethanamine;(z)-2-(para-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylamine;1-para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;ici47699;n-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-(z)-ethylamin;Nolvadex-D;tamoxifen(z) CAS: 10540-29-1 MF: C26H29NO MW: 371.51 EINECS: 234-118-0 Chemical Properties: White Crystalline Solid Usage :A nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. Tamoxifen is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines Usage: Tamoxifen is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is dependent upon PAX2. Blocks estradiol-stimulated VEGF production in breast tumor cells. Protein kinase C inhibitor. Induces apoptosis in human malignant glioma cell lines. Tamoxifen and its metabolite 4-hydroxytamoxifen are selective estrogen response mo difiers (SERMs) that act as estrogen antagonists in mammary gland. Blocks estradiol-stimulated VEGF production in breast tumor cells.
City:Wuhan Hubei[CN] 
Location:
 
Dec 19 2017hydrazine benzene sulfonamide hydrochloride471
Dec 19 2017Dutasteride418
Dec 19 2017Carboprost tromethamine //Carboprost411
Dec 19 2017Prostaglandin F2a tris salt441
Dec 19 2017Prostaglandin E1464
Dec 19 2017(-)-Corey Lactone Diol449
Dec 19 2017(-)-Corey lactone diol450
Dec 19 2017Cloprostenol sodium422
Dec 19 2017(+)-15(S)-CLOPROSTENOL /(±)-Cloprostenol455
Dec 19 2017(+)-Cloprostenol459

return back

Copyright © toextrade Inc. All rights reserved. Contact us